Joanne Reekie1, Christine Roberts2, David Preen3, Jane S Hocking4, Basil Donovan5, James Ward6, Donna B Mak7, Bette Liu8. 1. The Kirby Institute, University of New South Wales Sydney, Sydney, NSW, Australia. 2. Kolling Institute of Medical Research, University of Sydney, Sydney, NSW, Australia. 3. Centre for Health Services Research, University of Western Australia, Perth, WA, Australia. 4. School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia. 5. The Kirby Institute, University of New South Wales Sydney, Sydney, NSW, Australia; Sydney Sexual Health Centre, Sydney Hospital, Sydney, NSW, Australia. 6. Department of Infection and Immunity, South Australian Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia. 7. School of Medicine, The University of Notre Dame, Fremantle, WA, Australia. 8. School of Public Health and Community Medicine, University of New South Wales Sydney, Sydney, NSW, Australia. Electronic address: bette.liu@unsw.edu.au.
Abstract
BACKGROUND: Chlamydia trachomatis is one of the most commonly diagnosed sexually transmitted infections worldwide, but reports in the medical literature of an association between genital chlamydia infection and adverse obstetric outcomes are inconsistent. METHODS: The Western Australia Data Linkage Branch created a cohort of women of reproductive age by linking records of birth registrations with the electoral roll for women in Western Australia who were born from 1974 to 1995. The cohort was then linked to both chlamydia testing records and the state perinatal registry for data on preterm births and other adverse obstetric outcomes. We determined associations between chlamydia testing, test positivity, and adverse obstetric outcomes using multivariate logistic regression analyses. FINDINGS: From 2001 to 2012, 101 558 women aged 15 to 38 years had a singleton birth. Of these women, 3921 (3·9%) had a spontaneous preterm birth, 9762 (9·6% of 101 371 women with available data) had a baby who was small for gestational age, and 682 (0·7%) had a stillbirth. During their pregnancy, 21 267 (20·9%) of these women had at least one chlamydia test record, and 1365 (6·4%) of those tested were positive. Before pregnancy, 19 157 (18·9%) of these women were tested for chlamydia, of whom 1595 (8·3%) tested positive for chlamydia. Among all women with a test record, after adjusting for age, ethnicity, maternal smoking, and history of other infections, we found no significant association between a positive test for chlamydia and spontaneous preterm birth (adjusted odds ratio 1·08 [95% CI 0·91-1·28]; p=0·37), a baby who was small for gestational age (0·95 [0·85-1·07]; p=0·39), or stillbirth (0·93 [0·61-1·42]; p=0·74). INTERPRETATION: A genital chlamydia infection that is diagnosed and, presumably, treated either during or before pregnancy does not substantially increase a woman's risk of having a spontaneous preterm birth, having a baby who is small for gestational age, or having a stillbirth. FUNDING: Australian National Health and Medical Research Council.
BACKGROUND:Chlamydia trachomatis is one of the most commonly diagnosed sexually transmitted infections worldwide, but reports in the medical literature of an association between genital chlamydia infection and adverse obstetric outcomes are inconsistent. METHODS: The Western Australia Data Linkage Branch created a cohort of women of reproductive age by linking records of birth registrations with the electoral roll for women in Western Australia who were born from 1974 to 1995. The cohort was then linked to both chlamydia testing records and the state perinatal registry for data on preterm births and other adverse obstetric outcomes. We determined associations between chlamydia testing, test positivity, and adverse obstetric outcomes using multivariate logistic regression analyses. FINDINGS: From 2001 to 2012, 101 558 women aged 15 to 38 years had a singleton birth. Of these women, 3921 (3·9%) had a spontaneous preterm birth, 9762 (9·6% of 101 371 women with available data) had a baby who was small for gestational age, and 682 (0·7%) had a stillbirth. During their pregnancy, 21 267 (20·9%) of these women had at least one chlamydia test record, and 1365 (6·4%) of those tested were positive. Before pregnancy, 19 157 (18·9%) of these women were tested for chlamydia, of whom 1595 (8·3%) tested positive for chlamydia. Among all women with a test record, after adjusting for age, ethnicity, maternal smoking, and history of other infections, we found no significant association between a positive test for chlamydia and spontaneous preterm birth (adjusted odds ratio 1·08 [95% CI 0·91-1·28]; p=0·37), a baby who was small for gestational age (0·95 [0·85-1·07]; p=0·39), or stillbirth (0·93 [0·61-1·42]; p=0·74). INTERPRETATION: A genital chlamydia infection that is diagnosed and, presumably, treated either during or before pregnancy does not substantially increase a woman's risk of having a spontaneous preterm birth, having a baby who is small for gestational age, or having a stillbirth. FUNDING: Australian National Health and Medical Research Council.
Authors: Ashley V Hill; Maria Perez-Patron; Carmen D Tekwe; Ramkumar Menon; Deanna Hairrell; Brandie D Taylor Journal: Sex Transm Dis Date: 2020-04 Impact factor: 2.830
Authors: Chelsea Lee Shannon; Claire Bristow; Nicole Hoff; Adriane Wynn; Minh Nguyen; Andrew Medina-Marino; Jeanne Cabeza; Anne Rimoin; Jeffrey D Klausner Journal: Sex Transm Dis Date: 2018-10 Impact factor: 2.830
Authors: Weiming Tang; Jessica Mao; Katherine T Li; Jennifer S Walker; Roger Chou; Rong Fu; Weiying Chen; Toni Darville; Jeffrey Klausner; Joseph D Tucker Journal: Sex Transm Infect Date: 2019-12-13 Impact factor: 3.519
Authors: Jayalakshmi Ravindran; Barbra A Richardson; John Kinuthia; Jennifer A Unger; Alison L Drake; Lusi Osborn; Daniel Matemo; Janna Patterson; R Scott McClelland; Grace John-Stewart Journal: J Infect Dis Date: 2021-12-15 Impact factor: 5.226
Authors: Eline L M Op de Coul; Demi Peek; Yolanda W M van Weert; Servaas A Morré; Ingrid Rours; Chantal Hukkelhoven; Ank de Jonge; Birgit van Benthem; Monique Pereboom Journal: Reprod Health Date: 2021-06-26 Impact factor: 3.223